BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

FDA letter causes hurdle in GT's plan for LuViva U.S. approval

Jan. 24, 2012
By Omar Ford
Disappointment and frustration are perhaps two terms that best describe the tone of Guided Therapeutics' (Norcross, Georgia) conference call revealing the news about the company receiving a not approvable letter from the FDA for its LuViva device.
Read More

Financings roundup: 'Little Engine' AirXpanders raises $10M in 'D' round

Jan. 24, 2012
By Amanda Pedersen

Report from Europe: FzioMed receives CE mark for Dynavisc adhesion barrier gel

Jan. 24, 2012

Washington roundup: New de novo process seen as no leaner than current process

Jan. 24, 2012
By Mark McCarty

Agreements/contracts: Amarantus to work with Power3 for NuroPro test

Jan. 24, 2012

Coming Wednesday in MDD Perspectives

Jan. 24, 2012

Court report: Boston Sci wins latest round in patent suit filed by J&J

Jan. 24, 2012
Message pad with pen

When technology fails - and trust me, it will

Jan. 23, 2012
By Amanda Pedersen
Nearly every day at MDD we report on the latest advances in health IT, one of the fastest growing sectors in the industry.  It seems like new HIT and systems-related companies are cropping up every week, promising to enhance communication between patients and providers, and improve clinical workflow. But what happens when this technology fails – and trust me, it will – and the people trained to use these fancy pants systems are not taught how to go back to the basics, a.k.a. the pen-and-paper method? Let me give you an example from my own recent experience with the military’s...
Read More

HIT roundup: Apelon says DTS software supports open-source SQL

Jan. 23, 2012

MDD's Neurology Extra

Jan. 23, 2012
Previous 1 2 … 3962 3963 3964 3965 3966 3967 3968 3969 3970 … 10250 10251 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

    BioWorld Science
    Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing